pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›DisPATCH
drug
save

DisPATCH

Preclinicalupdated 6mo ago
by RootPath Genomics Inc
Preclinical
community read0 votes

all catalysts(0)

nothing on the calendar yet

News(10)

  • Summit’s rejection, Isomorphic’s record $5B raise, obesity and Alzheimer’s in the spotlight
    The FDA declined to approve Summit Therapeutics’ Akeso-partnered ivonescimab, putting other PD-1/VEGF drug developers on notice; Isomorphic bagged a $5 billion series C, the largest in biotech hist…
    biospace · 9h ago
  • Faith-based addiction recovery groups don’t often get federal funding. RFK Jr. wants to change that
    As RFK Jr. pushes federal support for faith-based recovery groups, medical experts express concern over access to addiction medications.
    stat · 1d ago
  • Critical decisions that spurred these 40 Under 40 winners to success
    Securing financing that allowed an exit from academia, leaving ecology and evolutionary biology for biomedical engineering and shifting from business development to entrepreneurship are among key t…
    biospace · 27d ago
  • BioSpace 40 Under 40 winners make their mark on biopharma
    40 Under 40 honorees’ accomplishments include co-developing the world’s first synthetic biology programming language for mRNA and co-founding and leading a company acquired for $700 million up-fron…
    biospace · 1mo ago
  • The FDA’s Overton era, and dispatches from Shanghai
    The Readout LOUD is going international this week with a dispatch from Shanghai, along with notes on the FDA's Overton era.
    stat · 1mo ago
  • New federal autism committee head has financial ties to leucovorin
    RFK Jr. has installed John Gaitanis, a pediatric neurologist, as the new chair of the Interagency Autism Coordinating Committee, which helps the federal government decide how to allocate roughly $2…
    stat · 1mo ago
  • Who supports policies for ‘health equity’? It depends on how you’re asking
    Kennedy speaks at the Children's Health Defense, medical facilities under attack in Sudan, and more health news from Morning Rounds
    stat · 2mo ago
  • STAT+: We’re reading about drug pricing deals, a new cancer therapy approval, and more
    In today's Pharmalittle newsletter, drug pricing deals, a new cancer therapy approval, and more of the latest pharma headlines.
    stat · 2mo ago
  • STAT+: Why Schrödinger CEO Ramy Farid changed how he’s thinking about AI
    In this edition of STAT's AI Prognosis: Why Schrödinger CEO Ramy Farid is rethinking AI, Recursion's neuron map, and more health AI news.
    stat · 3mo ago
  • STAT+: Why benchmarking clinical LLMs from OpenEvidence, Doximity is complicated
    In this edition of AI Prognosis: A conversation about benchmarking leading clinical chatbots, investor view on AI in biopharma, and more.
    stat · 3mo ago
view all news mentions →
indication
Solid Tumor
phase
preclinical
Data sources
ClinicalTrials.gov
last refreshed 8h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?